The 5,000 implants were among Tranquil’s entire portfolio, including its ALIF, TLIF and DLIF devices, according to an Oct. 11 news release from the company.
“Through compliant mechanism engineering, we are able to appropriately and precisely match the stiffness of Tranquil to cancellous bone,” David Hawkes, president of Nexus Spine, said in the release. “This creates a safe zone of mechanical loading that promotes bone formation and stability through more rapid implant integration with the vertebral endplate.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
